Which melanoma patient carries a BRAF-mutation?: a comparison of predictive models

Background: In patients with advanced melanoma the detection of BRAF mutations is considered mandatory before the initiation of an expensive treatment with BRAF/MEK inhibitors. Sometimes it is difficult to perform such an analysis if archival tumor tissue is not available and fresh tissue has to be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eigentler, Thomas (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 02, 2016
In: OncoTarget
Year: 2016, Jahrgang: 7, Heft: 24, Pages: 36130-36137
ISSN:1949-2553
DOI:10.18632/oncotarget.9143
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.9143
Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094988/
Volltext
Verfasserangaben:Thomas Eigentler, Zeinab Assi, Jessica C. Hassel, Lucie Heinzerling, Hans Starz, Mark Berneburg, Jürgen Bauer, Claus Garbe

MARC

LEADER 00000caa a2200000 c 4500
001 1585945056
003 DE-627
005 20220815085038.0
007 cr uuu---uuuuu
008 190107s2016 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.9143  |2 doi 
035 |a (DE-627)1585945056 
035 |a (DE-576)515945056 
035 |a (DE-599)BSZ515945056 
035 |a (OCoLC)1341031691 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eigentler, Thomas  |d 1973-  |e VerfasserIn  |0 (DE-588)128389710  |0 (DE-627)372633439  |0 (DE-576)187039062  |4 aut 
245 1 0 |a Which melanoma patient carries a BRAF-mutation?  |b a comparison of predictive models  |c Thomas Eigentler, Zeinab Assi, Jessica C. Hassel, Lucie Heinzerling, Hans Starz, Mark Berneburg, Jürgen Bauer, Claus Garbe 
264 1 |c May 02, 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.01.2019 
520 |a Background: In patients with advanced melanoma the detection of BRAF mutations is considered mandatory before the initiation of an expensive treatment with BRAF/MEK inhibitors. Sometimes it is difficult to perform such an analysis if archival tumor tissue is not available and fresh tissue has to be collected. Results: 514 of 1170 patients (44%) carried a BRAF mutation. All models revealed age and histological subtype of melanoma as the two major predictive variables. Accuracy ranged from 0.65-0.71, being best in the random forest model. Sensitivity ranged 0.76-0.84, again best in the random forest model. Specificity was low in all models ranging 0.51-0.55. Methods: We collected the clinical data and mutational status of 1170 patients with advanced melanoma and established three different predictive models (binary logistic regression, classification and regression trees, and random forest) to forecast the BRAF status. Conclusions: Up to date statistical models are not able to predict BRAF mutations in an acceptable accuracy. The analysis of the mutational status by sequencing or immunohistochemistry must still be considered as standard of care. 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 7(2016), 24, Seite 36130-36137  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Which melanoma patient carries a BRAF-mutation? a comparison of predictive models 
773 1 8 |g volume:7  |g year:2016  |g number:24  |g pages:36130-36137  |g extent:8  |a Which melanoma patient carries a BRAF-mutation? a comparison of predictive models 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.9143  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094988/  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190107 
993 |a Article 
994 |a 2016 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 3 
999 |a KXP-PPN1585945056  |e 3039141457 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.18632/oncotarget.9143"],"eki":["1585945056"]},"name":{"displayForm":["Thomas Eigentler, Zeinab Assi, Jessica C. Hassel, Lucie Heinzerling, Hans Starz, Mark Berneburg, Jürgen Bauer, Claus Garbe"]},"note":["Gesehen am 07.01.2019"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"a comparison of predictive models","title_sort":"Which melanoma patient carries a BRAF-mutation?","title":"Which melanoma patient carries a BRAF-mutation?"}],"relHost":[{"pubHistory":["1.2010,Mai -"],"origin":[{"dateIssuedKey":"2010","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"2010-","publisher":"Impact Journals LLC"}],"title":[{"subtitle":"open access impact journal","title":"OncoTarget","title_sort":"OncoTarget"}],"part":{"text":"7(2016), 24, Seite 36130-36137","extent":"8","issue":"24","pages":"36130-36137","volume":"7","year":"2016"},"id":{"zdb":["2560162-3"],"issn":["1949-2553"],"eki":["63035975X"]},"note":["Gesehen am 16.08.2018"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"63035975X","physDesc":[{"extent":"Online-Ressource"}],"disp":"Which melanoma patient carries a BRAF-mutation? a comparison of predictive modelsOncoTarget"}],"person":[{"display":"Eigentler, Thomas","family":"Eigentler","role":"aut","given":"Thomas"},{"family":"Hassel","role":"aut","given":"Jessica C.","display":"Hassel, Jessica C."}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"May 02, 2016"}],"physDesc":[{"extent":"8 S."}],"recId":"1585945056"} 
SRT |a EIGENTLERTWHICHMELAN0220